These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 37243988)
1. Evaluation of a DoE based approach for comprehensive modelling of the effect of lipid nanoparticle composition on nucleic acid delivery. Qin Y; Walters AA; Rouatbi N; Wang JT; Abdel-Bar HM; Al-Jamal KT Biomaterials; 2023 Aug; 299():122158. PubMed ID: 37243988 [TBL] [Abstract][Full Text] [Related]
2. Lipid nanoparticle formulations for optimal RNA-based topical delivery to murine airways. Tam A; Kulkarni J; An K; Li L; Dorscheid DR; Singhera GK; Bernatchez P; Reid G; Chan K; Witzigmann D; Cullis PR; Sin DD; Lim CJ Eur J Pharm Sci; 2022 Sep; 176():106234. PubMed ID: 35688311 [TBL] [Abstract][Full Text] [Related]
3. Chemistry of Lipid Nanoparticles for RNA Delivery. Eygeris Y; Gupta M; Kim J; Sahay G Acc Chem Res; 2022 Jan; 55(1):2-12. PubMed ID: 34850635 [TBL] [Abstract][Full Text] [Related]
5. Electrostatic adsorption of polyanions onto lipid nanoparticles controls uptake, trafficking, and transfection of RNA and DNA therapies. Nabar N; Dacoba TG; Covarrubias G; Romero-Cruz D; Hammond PT Proc Natl Acad Sci U S A; 2024 Mar; 121(11):e2307809121. PubMed ID: 38437543 [TBL] [Abstract][Full Text] [Related]
6. Electrophoretic Microfluidic Characterization of mRNA- and pDNA-Loaded Lipid Nanoparticles. De Peña AC; Zimmer D; Gutterman-Johns E; Chen NM; Tripathi A; Bailey-Hytholt CM ACS Appl Mater Interfaces; 2024 May; 16(21):26984-26997. PubMed ID: 38753459 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and Characterization of Aptamer-Targeted SNALPs for the Delivery of siRNA. Wilner SE; Levy M Methods Mol Biol; 2016; 1380():211-24. PubMed ID: 26552829 [TBL] [Abstract][Full Text] [Related]
8. Intracellular trafficking kinetics of nucleic acid escape from lipid nanoparticles via fluorescence imaging. M Bailey-Hytholt C; Ulinski G; Dugas J; Haines M; Lazebnik M; Piepenhagen P; E Zarraga I; Bandekar A Curr Pharm Biotechnol; 2023 Apr; ():. PubMed ID: 37016519 [TBL] [Abstract][Full Text] [Related]
9. Development of Polymer-Lipid Hybrid Nanoparticles for Large-Sized Plasmid DNA Transfection. Maeki M; Uno S; Sugiura K; Sato Y; Fujioka Y; Ishida A; Ohba Y; Harashima H; Tokeshi M ACS Appl Mater Interfaces; 2024 Jan; 16(2):2110-2119. PubMed ID: 38141015 [TBL] [Abstract][Full Text] [Related]
16. Optimization of DOTAP/chol Cationic Lipid Nanoparticles for mRNA, pDNA, and Oligonucleotide Delivery. Sun M; Dang UJ; Yuan Y; Psaras AM; Osipitan O; Brooks TA; Lu F; Di Pasqua AJ AAPS PharmSciTech; 2022 May; 23(5):135. PubMed ID: 35534697 [TBL] [Abstract][Full Text] [Related]
17. The use of design of experiments with multiple responses to determine optimal formulations for in vivo hepatic mRNA delivery. Hashiba A; Toyooka M; Sato Y; Maeki M; Tokeshi M; Harashima H J Control Release; 2020 Nov; 327():467-476. PubMed ID: 32853732 [TBL] [Abstract][Full Text] [Related]
18. Helper lipid structure influences protein adsorption and delivery of lipid nanoparticles to spleen and liver. Zhang R; El-Mayta R; Murdoch TJ; Warzecha CC; Billingsley MM; Shepherd SJ; Gong N; Wang L; Wilson JM; Lee D; Mitchell MJ Biomater Sci; 2021 Feb; 9(4):1449-1463. PubMed ID: 33404020 [TBL] [Abstract][Full Text] [Related]
19. Which Lipid Nanoparticle (LNP) Designs Work? A Simple Kinetic Model Linking LNP Chemical Structure to In Vivo Delivery Performance. Roh EH; Sullivan MO; Epps TH ACS Appl Mater Interfaces; 2024 Mar; 16(11):13399-13410. PubMed ID: 38466900 [TBL] [Abstract][Full Text] [Related]
20. A lipid nanoparticle platform for mRNA delivery through repurposing of cationic amphiphilic drugs. Bogaert B; Sauvage F; Guagliardo R; Muntean C; Nguyen VP; Pottie E; Wels M; Minnaert AK; De Rycke R; Yang Q; Peer D; Sanders N; Remaut K; Paulus YM; Stove C; De Smedt SC; Raemdonck K J Control Release; 2022 Oct; 350():256-270. PubMed ID: 35963467 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]